Judith A. Aberg, MD

Chief of Division of Infectious Diseases
Icahn School of Medicine at Mount Sinai

Poster(s):

• (365) Durable efficacy and robust CD4+ T-cell count improvement observed across age, race, sex, and geographic subgroups of heavily treatment-experienced people with multidrug-resistant HIV-1 after 240 weeks of fostemsavir treatment
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET